GlobeNewswire Inc. • Ispecimen Inc. iSpecimen Inc. Announces Pricing of ~$5.5 Million Private Placement
12/30/2025 02:37 PM • iSpecimen Inc. (Nasdaq: ISPC), an online marketplace for biospecimens, announced a securities purchase agreement with accredited investors for approximately $5.5 million in gross proceeds. The company will issue 6,875 shares of Series C Convertible Preferred Stock at $800 per share, convertible into common stock at 85% of the closing price. Net proceeds will be used for marketing, working capital, and general corporate purposes, with the offering expected to close on December 31, 2025.
UNH - Company mentioned as part of new trading product offering, with no specific positive or negative context
ISPC - The company is raising capital to fund operations and growth, which is a standard business activity. However, the offering of convertible preferred stock at a discount (85% conversion price) and the need for external funding could indicate financial constraints or dilution concerns for existing shareholders. The announcement itself is factual with no indication of operational challenges or successes.
ISPC - The company is raising capital to fund operations and growth, which is a standard business activity. However, the offering of convertible preferred stock at a discount (85% conversion price) and the need for external funding could indicate financial constraints or dilution concerns for existing shareholders. The announcement itself is factual with no indication of operational challenges or successes.
#capital raise
#preferred stock offering
#biospecimens marketplace
#private placement
#accredited investors
#convertible securities
Read More
The Motley Fool • Scott Levine 
Benzinga • Anusuya Lahiri 
Investing.com • Jordan Chussler 
